Taken altogether, the data that we have reported here are quite consistent with the contribution of GALNT2 to several highly prevalent metabolic abnormalities sharing the common ground of insulin resistance, namely atherogenic dyslipidemia, type 2 diabetes and obesity. The gene discussed is GALNT2; the disease is obesity due to melanocortin 4 receptor deficiency.